Rapid Medical
Latest round
- Series D
Last raised
- May 2021
Total raised
- $79M
Investors
- 10
About Rapid Medical
Founded in 2008 and based in Yokneam, Israel, Rapid Medical Ltd. operates as a developer of neurovascular interventional devices. Ronen Eckhouse and Shimon Eckhouse are the co-founders of the company. The company's products include Tigertriever, Tigertriever13, TigertrieverXL, which are adjustable clot retrievers for the treatment of ischemic stroke, and Comaneci, an adjustable remodeling mesh for the treatment of brain aneurysm, and also Columbus, a steerable guidewire. The organization is committed to advancing patient care by providing reliable, easy to use and high-quality products proven by clinical data.
Who invested in Rapid Medical
10 investors across 3 rounds
See all investors in Rapid Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rapid Medical
Who invested in Rapid Medical?
Rapid Medical has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rapid Medical raised?
Rapid Medical has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Rapid Medical last raise money?
Rapid Medical's most recent round on record is a Series D, in May 2021.
What does Rapid Medical do?
Founded in 2008 and based in Yokneam, Israel, Rapid Medical Ltd.
Where is Rapid Medical headquartered?
Rapid Medical is headquartered in Yokneam Illit, Israel.
Which VCs invest in companies like Rapid Medical?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Rapid Medical's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series D
Raising like Rapid Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.